Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens

Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens

Abstract Background There are conflicting data regarding the risk of hepatocellular carcinoma (HCC) after direct-acting antiviral agent (DAA) treatment. Risk of HCC in HCV genotype-3 infected persons after DAA therapy is not well known. Methods We prospectively studied HCV infected persons initiated...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Ghias Un Nabi Tayyab, Shafqat Rasool, Bilal Nasir, Ghazala Rubi, Abdul-Badi Abou-Samra, Adeel A. Butt
Format: Artikel
Sprache:English
Veröffentlicht: BMC 2020-04-01
Schriftenreihe:BMC Gastroenterology
Schlagworte:
Hepatocellular carcinoma
HCV genotype 3
DAA
Pakistan
Online Zugang:http://link.springer.com/article/10.1186/s12876-020-01249-4

Online

http://link.springer.com/article/10.1186/s12876-020-01249-4

Ähnliche Einträge